Hi [[ session.user.profile.firstName ]]

Best practices for submitting to Lancet journals and open access options

Do you want advice on how to prepare your manuscripts for publication in the best open access journals for your research? You are invited to join our webinar with Pooja Jha, Editor-in-Chief of The Lancet Regional Health – Europe, to learn techniques and strategies to set yourself up for publishing success. Dr. Jha will also share details about the growth of the Lancet journals portfolio, focusing on the open access options offered within the portfolio. Join this engaging webinar and get answers to your questions during the Q&A session.

Presented by:
Pooja Jha is the Editor-in-Chief of The Lancet Regional Health – Europe. Prior to this role, she worked at Nature Research in Berlin as an editor of Nature Metabolism and contributed to the launch of the journal since 2018. Pooja has a BSc degree in Chemistry, Botany, Zoology, and a MSc degree in Medical Molecular Biology and Human Genetics from India. She obtained her PhD in Molecular Medicine at the Medical University of Graz (Austria) where she investigated the role of adipose tissue and liver cross-talk in NAFLD progression. This was followed by her postdoctoral research in computational genetics, mitochondrial supercomplexes, ageing, and metabolic diseases at EPFL (Switzerland).

About The Lancet Regional Health - Europe:
The Lancet Regional Health – Europe is a new open access journal, part of The Lancet's global initiative to advocate for health-care quality and access in all regions of the world. The journal fosters the advance of clinical practice and health policy in the European region, with the ultimate goal of improving health outcomes. The journal aspires to increase the quality of regional and national health research.

The journal invites submissions that are pertaining to regional health topics, including but not limited to prevention and management of infections and non-communicable diseases, improvement of healthy ageing, and reduction of health inequalities.
Recorded May 6 2021 73 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Pooja Jha, Editor-in-Chief, The Lancet Regional Health - Europe
Presentation preview: Best practices for submitting to Lancet journals and open access options

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Best practices for submitting to Lancet journals and open access options Recorded: Sep 15 2021 73 mins
    Pooja Jha, Editor-in-Chief, The Lancet Regional Health - Europe
    Do you want advice on how to prepare your manuscripts for publication in the best open access journals for your research? You are invited to join our webinar with Pooja Jha, Editor-in-Chief of The Lancet Regional Health – Europe, to learn techniques and strategies to set yourself up for publishing success. Dr. Jha will also share details about the growth of the Lancet journals portfolio, focusing on the open access options offered within the portfolio. Join this engaging webinar and get answers to your questions during the Q&A session.

    Presented by:
    Pooja Jha is the Editor-in-Chief of The Lancet Regional Health – Europe. Prior to this role, she worked at Nature Research in Berlin as an editor of Nature Metabolism and contributed to the launch of the journal since 2018. Pooja has a BSc degree in Chemistry, Botany, Zoology, and a MSc degree in Medical Molecular Biology and Human Genetics from India. She obtained her PhD in Molecular Medicine at the Medical University of Graz (Austria) where she investigated the role of adipose tissue and liver cross-talk in NAFLD progression. This was followed by her postdoctoral research in computational genetics, mitochondrial supercomplexes, ageing, and metabolic diseases at EPFL (Switzerland).

    About The Lancet Regional Health - Europe:
    The Lancet Regional Health – Europe is a new open access journal, part of The Lancet's global initiative to advocate for health-care quality and access in all regions of the world. The journal fosters the advance of clinical practice and health policy in the European region, with the ultimate goal of improving health outcomes. The journal aspires to increase the quality of regional and national health research.

    The journal invites submissions that are pertaining to regional health topics, including but not limited to prevention and management of infections and non-communicable diseases, improvement of healthy ageing, and reduction of health inequalities.
  • COVID-19 Vaccines: An Update on Research & Global Availability Recorded: Sep 14 2021 62 mins
    John McConnell | Editor-in-Chief, The Lancet Infectious Diseases (London, United Kingdom)
    Join John McConnell, Editor-in-Chief of The Lancet Infectious Diseases to update yourself on the latest scientific viewpoints regarding the workings of the COVID-19 vaccines. In this professional webinar, John will cover areas such as:
    • Effectiveness of vaccines in preventing disease, including variant viruses
    • Vaccine safety – reactogenicity, anaphylaxis, clotting disorders, Bell’s palsy
    • What vaccines are available and their mechanisms of action
    • The path to making vaccines available worldwide
    • How has the pandemic affected the research landscape
    Moreover, you will get the opportunity to secure answers to your own pressing questions. You won’t want to miss this valuable webinar.

    About the presenter:
    John McConnell studied clinical microbiology and parasitology at the University of East London, before spending 6 years researching septic-shock-related topics at the Royal Postgraduate Medical School, Hammersmith Hospital, London (now part of Imperial College London). He joined The Lancet in 1990 as a peer-review editor before becoming the first Web Editor in 1996. In 2001, John was the founding editor of The Lancet Infectious Diseases. He has appeared as an expert commentator on BBC, ITV, Channel 4, Sky News, Al Jazeera, CNBC, CNN, and CCTV America. In the past year, The Lancet Infectious Diseases has published some of the most impactful research on COVID-19.
  • Accessible high-throughput experimentation from startup to scale Recorded: Aug 4 2021 52 mins
    Timothy Cernak, Danielle Schultz, Jacob Janey, and Matthew Gaunt | Moderators: Kristina Vrouwenvelder and Michelle Muzzio
    High-throughput experimentation (HTE) is a powerful tool in chemistry, allowing exploration of a wide range of reaction conditions, substrates, and other variables and generating datasets of use in applying machine learning methods to chemical prediction. But HTE can sometimes be viewed as inaccessible to the academic chemist, while also presenting unique challenges in data analysis and management. In this panel, Tim Cernak, Dani Schultz, Jacob Janey, and Matthew Gaunt will discuss the myths surrounding HTE (7:52), the challenges and benefits of employing it in academia and industry (22:32), how to get started with HTE (36:36), and the future of the field (44:33).

    Tim Cernak is an Assistant Professor of Medicinal Chemistry at the University of Michigan in Ann Arbor, where the Cernak Lab is exploring an interface of chemical synthesis and data science. Prior to the University of Michigan, Tim was a member of the Medicinal Chemistry team at Merck Sharp & Dohme.

    Dani Schultz is the Director of the Discovery Process Chemistry Group at Merck. During her time at Merck, she has been involved in the development of synthetic routes for drug candidates spanning HIV and oncology and has utilized HTE and photochemistry to address the synthetic challenges that occur during pharmaceutical development.

    Jacob Janey is the Senior Director of Scientific Computing at Vertex Pharmaceuticals. Prior to this, Jake worked at Merck and later led the Chemical Process Development Technology Group at Bristol-Meyers Squibb. His work has included developing manufacturing routes using robotics, machine learning, HTE, and catalysis as well as data stewardship.

    Matthew Gaunt is the Yusuf Hamied 1702 Chair of Chemistry at the University of Cambridge. His research focuses on the development of new chemical reactivity enabled by catalysts, including metal-catalyzed C–H bond activation, photoredox catalysis, selective chemical modification of biomolecules, and high-throughput synthesis.
  • Med platforms Matter: Materials science for cancer diagnostics and treatment Recorded: Jun 23 2021 94 mins
    Natalie Artzi, Ali Khademhosseini, and Wei Tao | Moderators: Nikla Emambokus and Steve Cranford
    With the continued rise of interdisciplinary approaches bridging life and physical sciences, researchers are using every toolkit available to tackle the most pressing health problems. Med and Matter recognize that multiple driving technologies emerging in medicine are being developed on innovative and advanced materials platforms; these technologies exploit the behavior of novel materials and phenomena, including biocompatible chemistries and mechanics, adaptive structures, transport properties, photodynamics, and more. Simply put, the underlying platforms used for medicine matter. Here, we focus on materials-based solutions for potential cancer treatment, diagnostics, and the next generation of personalized medicine.

    About the speakers

    Dr. Ali Khademhosseini is the CEO of the Terasaki Institute for Biomedical Innovation. Formerly, he was the Levi Knight Professor of Bioengineering, Chemical Engineering, and Radiology at the University of California-Los Angeles (UCLA), and also a Professor at Harvard Medical School and the Wyss Institute. Khademhosseini is best known for developing hydrogels for tissue engineering and bioprinting.

    Dr. Natalie Artzi holds research appointments at Harvard Medical School, MIT, and the Broad Institute of MIT and Harvard. Dr. Artzi is the recipient of multiple grants and awards, including the One Brave Idea; Stepping Strong Innovator, and Breakthrough Awards; Controlled Release Society Young Investigator Award; Mid-Career Award from the Society for Biomaterials; and the Bright Futures Prize.

    Dr. Wei Tao is an assistant professor at the Harvard Medical School. Dr. Tao has received multiple awards and grants, including the U.S. METAvivor Early Career Investigator Award; Harvard Anesthesia Department Basic Scientist Grant; Khoury Innovation Award; Center for Nanomedicine Research Fund; Stepping Strong Breakthrough Innovator Award (Co-PI); and the American Heart Association (AHA) Collaborative Sciences Award (Co-PI).
  • How to Develop a Multi-disciplinary Clinical Research Career Recorded: Apr 20 2021 61 mins
    Bonnie Ky, MD, MSCE, FACC
    Join this interactive webinar session with Bonnie Ky, MD, MSCE, FACC, Editor-in-Chief of JACC: CardioOncology to learn strategies on how to develop a clinical research career, with examples of how to successfully ask and answer research questions in cardio-oncology. You can expect to learn about the following:
    - Important components of building a successful research career from scientific questions to team building
    - Grant submission
    - Overview of the publication process
    - Key challenges faced by every clinical researcher and how to tackle them to build a successful career

    Sign up for this engaging session with Dr. Bonnie Ky today and get an opportunity to find answers to your pressing questions during the Q&A session of the webinar.

    About Bonnie Ky, MD, MSCE, FACC:
    Dr. Bonnie Ky is the Founders Associate Professor of Medicine and Epidemiology and tenured physician-scientist at the University of Pennsylvania and serves as the Director for the Penn Center for Quantitative Echocardiography and is the founding Director of the Penn Cardio-Oncology Translational Center of Excellence. She leads a highly active NIH-funded translational research program in cardio-oncology and is the PI of multiple investigator-initiated cohort studies and clinical trials focused on the study of the cardiotoxic effects of doxorubicin, trastuzumab, sunitinib, and radiation therapy in breast, renal cell, and lung cancers, and lymphoma patients.
  • Introducing the Editor-in-Chief of Chem Catalysis Recorded: Jan 27 2021 3 mins
    Dr. Robert D. Eagling, Editor-in-Chief of Chem
    Get to know Dr. Ilaria Cianchetta, newly appointed Editor-in-Chief of the new journal Chem Catalysis and learn more about her vision for the first field-focused journal from the award-winning Cell Press chemistry title Chem.

    Chem Catalysis is a monthly journal publishing innovative and insightful research on fundamental and applied catalysis, providing a platform for researchers across chemistry, chemical engineering, and related fields to disseminate and promote their work. The journal is a premier resource for scientists, researchers, and engineers in both academia and industry, bridging the multidisciplinary aspects and scales of the field.
    Chem Catalysis publishes experimental and theoretical studies in all fields of catalysis—heterogeneous catalysis, homogeneous catalysis, and biocatalysis—that report transformative methods, tools, and technologies that are of value to all communities. We give particular emphasis to reports that significantly advance our understanding of existing systems, expand the current knowledge with novel catalysts, and connect fundamental catalysis insights to the real world for the benefit of society.
  • Emerging technologies and clinical research in Latin America Recorded: Nov 18 2020 120 mins
    David Collingridge,Carlos Barrios,Eduado Cazap,Gustavo Werutsky,Georgina Sposetti,Rodrigo Dienstmann & Stephen Stephani
    Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. In 2013 and 2015, The Lancet Oncology published two Commissions that highlighted the cancer landscape in Latin America and how it differed from more developed countries. The reports showed that funding for health care was just a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funding, insurance coverage, numbers of doctors, health-care workers, resources, and equipment were inequitably distributed between and within Latin American countries. The Commissions emphasised the need for structural reforms in health-care systems, the need for dedicated cancer control programmes for disenfranchised populations, the importance of expanding coverage of cancer registries and cancer plans, and the effect of implementing policies to improve primary cancer prevention. In this webinar, renowned experts from Brazil, Argentina, and Spain, revisit cancer control in Latin America via a more contemporaneous lens, with a focus on the challenges surrounding academic research funding, clinical trial recruitment, big data, and wider access to the latest diagnostic technologies.
  • Sustainable care for children with cancer: a Lancet Oncology Commission Recorded: Nov 18 2020 116 mins
    Ali Landman, Carlos Rodriguez-Galindo, Kathy Pritchard-Jones, Rifat Atun
    Cancer kills more than 100,000 children each year, and yet 80% of pediatric cancers are curable with currently available interventions. Notably, the majority of these deaths occur in low‐income and middle-income countries. Yet no reliable data are available in low-income and middle-income countries on the burden of childhood cancer; on the cost of effective interventions; on current health coverage levels; or on the cost, feasibility, or health and economic benefits of scaling-up effective coverage.

    In March, 2020, The Lancet Oncology published a Commission on Sustainable care for children with cancer, which provided a new analysis of the global childhood cancer burden and developed an economic investment case and evidence-based medical framework for implementing, integrating, and scaling up care pathways for childhood cancer.

    Join Dr. Ali Landman, Deputy Editor of The Lancet Oncology, and Commission authors, as they discuss the aims, findings, and recommendations from the Commission.
  • How to publish with the Journal of Thoracic Oncology Recorded: Oct 29 2020 89 mins
    Dr. Alex Adjei, Editor-in-Chief, Journal of Thoracic Oncology
    Finding the right journal to publish your research and structuring your research to publish in high impact journals can be a challenge. Learn techniques and strategies to publish in high impact journals like the Journal of Thoracic Oncology with Dr. Alex Adjei, Editor-in-Chief.

    You can expect to learn about:
    -Manuscript preparation tips
    -Features of successful manuscripts
    -Fatal errors in manuscripts that lead to outright rejection
    -The editorial process
    -How to publish in JTO and its new spin-off JTO Clinical Research Reports
    -New initiatives at the Journal

    About Dr. Alex Adjei:
    Alex A. Adjei is a Professor of Oncology and Professor of Pharmacology in the Mayo College of Medicine. He is also a consultant in Medical Oncology at Mayo Clinic. Dr. Adjei is Director of the Early Cancer Therapeutics Program across all three Mayo Clinic sites, and leader of the Lung Cancer Program across all 3 Mayo Clinic sites. He is the Principal Investigator of the Mayo Phase I and Phase II NCI grants. Dr Adjei has served on a number of National Cancer Institute (US) Committees. He is currently co-chair of the Thoracic Malignancies Steering Committee. Dr Adjei is a past member of the IASLC Board of Directors. He is the Editor-in-Chief of the Journal of Thoracic Oncology and the inaugural Editor-in-Chief of JTO Clinical and Research Reports. Dr. Adjei’s research is focused on experimental therapeutics and clinical drug development. He received the first ASCO Drug Development Research Professorship 2012-2017, in recognition of his mentorship and his work in cancer drug development. He has authored 280 publications dealing primarily with preclinical pharmacology and phase I trials as well as novel therapeutics/phase II trials of lung cancer.
  • How to Become a Successful Researcher At Every Stage of Your Career Recorded: Oct 15 2020 91 mins
    Dr. Valentin Fuster, Editor-in-Chief, JACC & Dr. Harlan Krumholz, Cardiologist & Health Care Researcher at Yale University
    Pursuing a career as a physician-scientist can be daunting, especially as the success rates for securing research grants has declined from 33% to 19%, while the number of grant applications has increased by 72%. However, the pathway can provide personal and professional fulfillment and dynamism, if the individual is equipped with a roadmap for success. Valentin Fuster, MD, PhD, MACC, editor in chief of the Journal of the American College of Cardiology (JACC), and Harlan M. Krumholz, MD, SM, FACC, director of the Yale Center for Outcomes Research and Evaluation at Yale School of Medicine, will discuss how to maintain a successful physician-scientist career at three stages: early career, mid-career and senior. They will include tips for grant receipts, the importance of the mentee/mentorship relationship, and the need for creativity in grant submissions. In addition, viewers will have the opportunity to ask these thought leaders questions and pointers.

    About the presenters:
    Dr. Valentin Fuster serves The Mount Sinai Hospital as Physician-in-Chief, as well as Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. He is also the Richard Gorlin, MD/Heart Research Foundation Professor, Icahn School of Medicine at Mount Sinai.

    Dr. Harlan Krumholz is a cardiologist and health care researcher at Yale University and Yale New Haven Hospital. He also serves as Director of the Yale Center for Outcomes Research and Evaluation (CORE) at Yale School of Medicine.

    Learn more about the JACC family of journals at JACC.org.
  • 化學、材料前沿科學學術線上論壇 Frontier Sciences online workshop:Chemistry & Materials Science Recorded: Oct 15 2020 92 mins
    Prof. Shen-Ming Chen, Taipei Tech, Prof. Ken-Tsung Wong, National Taiwan University, Dr. Fenglin Liao, Editor, Chem
    隨著科技技術的進步,新材料被發現與創造,或發展出新的應用方式,甚至是不同領域間的合作。除了不同領域間的合作,學術界與產業界間的連結若能夠深化,將能夠為雙邊帶來不同的發展。本次論壇邀請到在化學感測技術有深入研究的陳生明教授以及有機材料化學專家汪根欉教授來一同討論材料化學與結合不同領域的合作模式與發展。另外本次論壇也請汪根欉教授分享投稿到 Chem 的經驗,也邀請到 Cell Press 旗下 Chem期刊的廖鳳麟編輯為我們介紹 Cell Press 新的 Physical Science 期刊 Chem, Joule, Trends in Chemistry, Matter 及如何提高發表在高影響力期刊的機會與技巧。The webinar language will be Taiwan Chinese.
  • Cell Press细胞出版社介绍及研究者资源分享 Recorded: Sep 29 2020 55 mins
    Head of Strategy and Partnership in Greater China, Cell Press/Senior Scientific Editor, Cell
    与Cell(《细胞》)资深编辑谭家颖博士一道,了解Cell Press细胞出版社的创新之路,以及我们在多学科领域的发展和不断拓展的开放获取出版战略。

    你可以了解更多关于Cell Press细胞出版社为支持研究群体发展而提供的各类产品与服务,包括网络研讨会、Cell Mentor、Sneak Peek(先睹为快)、STAR Methods、STAR Protocols和更多可以帮助科研工作者和研究机构快速发展,并助力其在世界科研领域提升影响力的新项目。

    我们期待通过网络研讨会与您互动,回答您关于Cell Press细胞出版社的所有问题。在Cell Press细胞出版社,我们做的所有事情都是为了推动科研进步——不管是与作者携手合作,不断优化同行评议流程,还是推动出版领域的创新。我们将科学放在第一位。科学终将推动人类社会进步。

    您可以通过如下网址收看网络研讨会(会议语言为英文):
    https://www.brighttalk.com/webcast/16651/381846

    您也可以带上您的同事和朋友,一起与谭家颖博士加入这场网络研讨会,收获更多。
  • Clinical Cases & Social Media: Tips & Techniques Recorded: Sep 8 2020 72 mins
    Dr. Julia Grapsa, Editor-in-Chief, JACC: Case Reports & Dr. Mary Norine Walsh, MD, FACC, President, ACC
    In order to create the right impact, researchers must first prepare their clinical case for successful submission and once published – work to ensure visibility of their findings for the benefit of the wider public. Join our webinar with Julia Grapsa, MD, PhD, FACC, editor-in-chief of JACC: Case Reports and Mary Norine Walsh, MD, MACC, deputy editor of JACC: Case Reports and past president of the ACC. You can expect to learn:
    • How to prepare a clinical case report
    • Common mistakes in submitting case reports
    • A checklist to follow prior to submission
    • Best practices to bring visibility to your research via social media
    • Benefits of each platform type and how you can use them to your advantage
    • How researchers can network online effectively

    Sign up for this engaging webinar and get an opportunity to find answers to your questions during the Q&A session with Dr. Grapsa & Dr. Walsh.

    About Dr. Grapsa:
    Julia Grapsa, MD, PhD, FACC, is a consultant cardiologist at Guys and St Thomas NHS Trust, where she is responsible for the valvular heart disease network and echocardiography. Prior to her role as JACC: Case Reports editor-in-chief, Dr. Grapsa served as an editorial consultant for JACC: Cardiovascular Imaging. Dr. Grapsa’s areas of research include valvular heart disease and the study of right heart remodelling.
    About Dr. Walsh:
    Mary Norine Walsh, MD, MACC is the medical director of the Heart Failure and Cardiac Transplantation Programs at St. Vincent Indianapolis Hospital; director of Nuclear Cardiology at The Care Group, a member of St. Vincent Medical Group; and clinical associate professor of Medicine at the Indiana University School of Medicine. Her areas of expertise include nuclear cardiology, congestive heart failure and cardiac transplantation with a special interest in women and heart disease.
  • Navigating the Publishing Process for High Impact Journals Recorded: Sep 8 2020 94 mins
    Dr. Luke Batchelor, Editor-in-Chief, Cell Reports Physical Sciences
    Join Luke Batchelor, Ph.D., Editor-in-Chief, Cell Reports Physical Sciences for an engaging webinar to learn about techniques and strategies for authoring in high impact journals. Luke will present his experience working with researchers and authors throughout the research publishing cycle, how to develop papers for premium publications, and the opportunity to broadly disseminate findings. Luke will talk to you about growth of Cell Press journals in the physical sciences field, which includes launch of many new titles such as Chem, Joule, Matter, and One Earth. He’ll also outline Cell Press’ approach to high-demand, multi-disciplinary content, and expanding OA publishing strategies at Cell Press. You won’t want to miss this informative webinar and how it can benefit your research process and impact. Please extend this invite to colleagues who may also find it of interest.

    More about Dr. Luke Batchelor:
    A chemist by training, Luke obtained his undergraduate degree from the University of Bristol and his PhD from the University of Manchester, which was then followed by postdoctoral work at Manchester and Université Paris Sud XI. In 2012, Luke moved to Nature Communications, covering a range of topics in chemistry and materials science; and in 2017, he led the launch of Communications Chemistry. Luke joined Cell Press in 2019 and is based in the London office
  • How to publish in groundbreaking journals Recorded: Aug 27 2020 88 mins
    Steve W. Cranford, Editor-in-Chief, Matter
    Would you like to learn tips for writing and developing a strong narrative for your work? Do you want advice on how to prepare your manuscripts for publication in the best journal for your research? Join us for a webinar with Steve W. Cranford, Editor-in-Chief, Matter to learn techniques and strategies to set yourself up for publishing success. Dr. Cranford will share details about the growth of multidisciplinary Cell Press journals and tips on developing your manuscript and will elaborate on his experience working with researchers throughout the publishing cycle. Join this engaging webinar and get answers to your questions in the Q&A session. Don’t forget to extend this invitation to your colleagues who might find this of interest.

    About Steve W. Cranford:
    A graduate from Memorial University (Canada), Stanford University (USA), and Massachusetts Institute of Technology (USA), Dr. Cranford was faculty at Northeastern University’s College of Engineering prior to accepting a new role as editor-in-chief for Matter.
    He has over 50 publications in the field of materials science in a range of high-impact journals, including Nature and Advanced Materials, with expertise in the area of atomistic simulation, computational modeling, and nanomechanics, encompassing a variety of materials systems, from carbyne to copper to concrete.
    He would have preferred to have published in Matter, but it didn’t exist. He constantly played with LEGO blocks as a child, likely leading to his interest in material assembly and structure.

    About the journal Matter:
    Matter, a sister journal to Cell, is a monthly journal encompassing the general field of materials science, from nano to macro and fundamentals to application. Recognizing that materials discovery and development facilitate groundbreaking technologies bridging multiple disciplines, Matter will embrace all significant advances in materials research, encompassing the previously unknown and the innovative.
  • Matter: It's Material Recorded: Aug 27 2020 1 min
    Steve W. Cranford, Editor-in-Chief, Matter
    Matter—a new journal from Cell Press and a sister to Cell, Chem, and Joule—is the home for multi-disciplinary, transformative materials science research.

    Join Steve W. Cranford, Editor-in-Chief, Matter to learn tips to publish in high impact journals. Sign up for the webinar here: https://www.brighttalk.com/webcast/16651/423683

    Explore other upcoming webinars from Matter here:
    1. Designing Quantum Materials using AI & Machine Learning: Opportunities for Collaboration : https://www.brighttalk.com/webcast/16651/430707

    2. Understanding materials for Quantum Information Processing : https://www.brighttalk.com/webcast/16651/430713
  • Understanding Materials for Quantum Information Processing Recorded: Aug 26 2020 114 mins
    Gary Wolfowicz, Sarabjit Banerjee and Danna Freedman
    Breakthroughs in the fundamental physics and chemistry of quantum materials are key for emerging technologies in computation, information processing, and communication. Interdisciplinary teams must consider both the nature of the quantum states and materials as well as issues of engineering and scalability. In this webinar, the speakers will discuss their pioneering works in the field of quantum information processing, including the synthesis of new materials and characterization of their underlying physical processes. Speakers will then participate in a future-looking panel discussion about what fundamental and applied questions still need to be answered to advance the field.

    Gary Wolfowicz, Argonne National Lab
    Gary Wolfowicz obtained his PhD at Oxford in 2015 and is currently a scientist at Argonne National Laboratory. He has been exploring spin defect properties such as qubit coherence in semiconductors. His interest includes discovering and applying novel materials for quantum sensing and communication.

    Sarbajit Banerjee, Texas A&M University
    Sarbajit Banerjee is the Davidson Professor of Chemistry, Professor of Materials Science and Engineering, and Chancellor EDGES Fellow at Texas A&M University. His research interests are focused on electron correlated solids, electronic structure studies at interfaces, metastable materials, and energy efficient computation. He is a Fellow of the Royal Society of Chemistry and the Institute of Physics.

    Danna Freedman, Northwestern University
    Danna Freedman joined the Chemistry Department at Northwestern University in 2012, where she was recently promoted to Full Professor. Research in her group applies inorganic chemistry to challenges in physics, with emphasis on quantum information science, magnetic materials, and emergent phenomena. Notable accomplishments of the Freedman lab include the observation of millisecond coherence times in molecular qubit candidates and creating the first Fe-Bi bond in the solid-state.
  • Designing Quantum Materials using AI & Machine Learning Recorded: Aug 26 2020 105 mins
    Maria K. Chan, Alán Aspuru-Guzik and Stephen Gray
    Artificial intelligence and machine learning (AI/ML) has sped up the discovery, synthesis, and characterization of quantum materials. The growth of this interdisciplinary field is driven by the collaboration of materials scientists, chemists, physicists, and more. This webinar will showcase advances from developing algorithms to understanding interactions in quantum materials to applying this knowledge in new technologies. Speakers will then discuss the interdisciplinary nature of AI/ML and collaborations with researchers, national labs, and companies.

    Maria K. Chan, Argonne
    Maria Chan obtained her PhD in Physics from MIT. Since 2012, Dr. Chan has been a staff scientist at Argonne’s Center for Nanoscale Materials. Her research focuses on the computational prediction of materials properties, using first principles, atomistic, and ML methods, particularly in applications toward energy technologies, such as energy storage, photovoltaics, catalysis, and thermal management.

    Stephen K. Gray, Argonne
    Stephen K. Gray is a Senior Scientist at Argonne’s Center for Nanoscale Materials. He has a PhD in Chemistry from UC Berkeley, and carried out post-doctoral work at Oxford and the University of Chicago. He is a Fellow of the American Physical Society, and his diverse research work is currently focused on modeling light-matter interactions in nanoscale materials, as well as hybrid materials for quantum information and quantum sensing.

    Alán Aspuru-Guzik, University of Toronto
    Alán Aspuru-Guzik is a Professor of Chemistry and Computer Science at the University of Toronto. He is a CIFAR AI Chair and CIFAR Fellow and Faculty member at the Vector Institute for Artificial Intelligence. He is interested in the intersections of quantum information and chemistry as well as the intersections of AI, automation and chemistry. He is a co-founder and officer of Zapata Computing, a quantum computing startup and Kebotix, a startup dedicated to self-driving laboratories.
  • Introducing the New Cell Press Title: Med Recorded: Aug 20 2020 1 min
    Med
    Med, a new journal from Cell Press, publishes transformative, evidence-based science across the clinical and translational research continuum – from large-scale clinical trials to translational studies with demonstrable functional impact, offering novel insights in disease understanding.

    We aim to elevate the global standard of medical research by accelerating translation of bench research to the clinic, serving as a hub for engagement between all stakeholders, improving reproducibility, and changing medical practice.
  • HIV-related haematological malignancies Recorded: Aug 13 2020 57 mins
    The Lancet Haematology and The Lancet HIV
    Since the earliest days of the HIV epidemic, haematological malignancies have been a defining feature of illness caused by the virus; individuals with HIV are living longer and contending with the challenges of treating cancer while on ART, now, work on haematological cancers is providing insights into how a cure for HIV might be achieved. Join Peter Hayward, Editor-in-Chief of The Lancet HIV, and the Series authors as they introduce and explore the findings from this new joint Series on HIV-related haematological malignancies from The Lancet Haematology and The Lancet HIV.

    About the Speakers:
    - Satish Gopal, National Cancer Institute Center for Global Health, Rockville, MD, USA
    - Ariela Noy, Memorial Sloan Kettering Cancer and Weill Medical College, New York, NY, USA
    - Thomas S. Uldrick, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    - Peter Hayward, The Lancet HIV, London, UK
Learn from editors of premium ground-breaking journals
As a researcher, you want to learn techniques and strategies to set yourself up for publishing success. On our premium content channel, you can find useful resources to learn the best practices on preparing manuscripts for publication and discovering the best journal for your research. Join esteemed editors from premium journals like Cell Press, The Lancet and Societies like ACC, AWHONN, AATS and many others to learn tips on publishing in top journals.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Best practices for submitting to Lancet journals and open access options
  • Live at: May 6 2021 12:00 pm
  • Presented by: Pooja Jha, Editor-in-Chief, The Lancet Regional Health - Europe
  • From:
Your email has been sent.
or close